Mechanistic evaluation of the effect of sintering on Compritol® 888 ATO matrices

AAPS PharmSciTech

Volumn 10, Issue 2, 2009, Pages 355-360

  Rao, Monica ^a   Ranpise, Anuradha ^a   Borate, Sameer ^a   Thanki, Kaushik ^a  

^a AISSMS COLLEGE OF PHARMACY   (India)

Author keywords

Controlled release; Scanning electron microscopy (SEM); Sintering; Wax

Indexed keywords

GLYCEROL BEHENATE; KETOROLAC TROMETAMOL; LACTOSE; TALC; WAX; FATTY ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CHEMICAL STRUCTURE; CONTACT ANGLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG MIXTURE; DRUG SOLUBILITY; DRUG STORAGE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MATRIX TABLET; ROOM TEMPERATURE; SCANNING ELECTRON MICROSCOPY; SINTERING; STORAGE TEMPERATURE; TABLET COMPRESSION; TABLET HARDNESS; TABLET MANUFACTURE; X RAY DIFFRACTION; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG STABILITY; PHARMACEUTICS; SOLUBILITY; TABLET; WETTABILITY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; FATTY ACIDS; KETOROLAC TROMETHAMINE; MICROSCOPY, ELECTRON, SCANNING; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS; TECHNOLOGY, PHARMACEUTICAL; WETTABILITY; X-RAY DIFFRACTION;

EID: 67549102404     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9211-8     Document Type: Article

References (15)

1. Y. Zhang, and B. Schwartz. Effect of processing method and heat treatment on formulation of wax matrix tablet. Pharm. Dev. Tech. 69:131-144 (2001).
2. S.B. Tiwari, T. Krishnamurthy, M.R. Pai, P. R. Mehta, and P.B. Choudhary. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS Pharm. Sci. Tech. 4:31 (2003).
3. C.L. Luk, and H.L. Jane. Sintering in pharmaceutics. In J. Swarbrick, and J. C. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, 14:2Nd ed., Marcel Dekker, New York, 1996, pp. 87-101.
4. S.B. Rao, P.S. Cheruvu, K.S. Sudha et al. Studies on release of rifampicin from sintered matrix tablets. Indian J. Pharm. Sci. 63:371-378 (2001).
5. S.B. Rao, A. Seshsayana, K. Himasankar et al. Design and evaluation of ethylene vinyl acetate sintered matrix tablets. Indian J. Pharm. Sci. 65:496-502 (2003).
6. A. Kondaiah, and K. Prakash. Design of controlled release non-erodible polymeric matrix tablets of theophylline using sintering technique. Indian J. Pharm. Sci. 64:239-243 (2002).
7. S.B. Rao, K.H. Sankar, and B.S. Sirisha. Design and evaluation of Eudragit RL100 sintered matrix tablets. Indian J. Pharm. Sci. 66:202-207 (2004).
8. S. Azarmi, J. Farid, A. Nokhodechi, and H. Valizadeh. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices. Int J. Pharm. 246:171-177 (2002).
9. D. Jung, E. Mroszczak, and L. Bynum. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration. Eur. J. Clin. Pharmacol. 35:423-425 (1988).
10. E.J. Mroszczak, F.W. Lee, and D. Combs. Ketorolac tromethamine absorption, distribution, metabolism, excretion and pharmacokinetics in animals and humans. Drug Metab. Dispos. 15:618-626 (1987).
11. J.B. Brubach, V. Jannin, B. Mahler, and P. Roy. Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. Int. J. Pharm. 336:248-256 (2007).
12. S.B. Souto, W. Mehnert, and R.H. Muller. Polymorphic behaviour of Compritol 888 ATO as a bulk lipid and as SLN and NLC. J. Microencapsul. 23 4:417-433 (2006).
13. R. Singh, S.S. Poddar, and A. Chivate. Sintering of wax for controlling release from pellets. AAPS Pharm. Sci. Tech. 8:E1-E9 (2007).
14. S. Azarmi, F. Ghaffari, R. Lobenberg, and A. Nokhodchi. Mechanistic evaluation of the effect of thermal treating on Eudragit RS matrices. II Farmaco. 60:925-930 (2005).
15. H.M. Abdou. Dissolution, Bioavailability and Bioequivalence, Mack, Easton, 1989.